Dusseldorf - Delayed Quote EUR
Trulieve Cannabis Corp (T0A.DU)
4.2200
+0.4540
+(12.06%)
At close: April 25 at 7:32:13 PM GMT+2
Loading Chart for T0A.DU
- Previous Close
3.7660 - Open
4.0940 - Bid 3.9260 x --
- Ask 4.1620 x --
- Day's Range
4.0840 - 4.2320 - 52 Week Range
2.7720 - 12.3900 - Volume
0 - Avg. Volume
131 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.DU
View MorePerformance Overview: T0A.DU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.DU
5.64%
S&P/TSX Composite index (^GSPTSE)
0.37%
1-Year Return
T0A.DU
55.95%
S&P/TSX Composite index (^GSPTSE)
12.91%
3-Year Return
T0A.DU
71.86%
S&P/TSX Composite index (^GSPTSE)
17.60%
5-Year Return
T0A.DU
80.51%
S&P/TSX Composite index (^GSPTSE)
71.36%
Compare To: T0A.DU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.2200
+12.06%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4940
+37.22%
Mkt Cap EUR 201.371M
Industry Drug Manufacturers—Specialty & Generic
0.9360
-0.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.9200
0.00%
Mkt Cap EUR 340.492M
Industry Drug Manufacturers—Specialty & Generic
3.7400
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4378
+12.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.6120
+4.47%
Mkt Cap EUR 623.101M
Industry Drug Manufacturers—Specialty & Generic
0.4400
+12.27%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.28
+14.73%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.29
+15.09%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.DU
View MoreValuation Measures
As of 4/25/2025
Market Cap
752.30M
Enterprise Value
1.22B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.77
Price/Book (mrq)
0.72
Enterprise Value/Revenue
1.16
Enterprise Value/EBITDA
4.87
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--